The Relationship between Acute Dyskinesia with a Single Dose of Methylphenidate and Recent Risperidone Discontinuation in a Child with Attention-Deficit/Hyperactivity Disorder-Reference-Cited by-同舟云学术

The Relationship between Acute Dyskinesia with a Single Dose of Methylphenidate and Recent Risperidone Discontinuation in a Child with Attention-Deficit/Hyperactivity Disorder

Published:2015-05 Issue:4 Volume:25 Page:378-379
ISSN:1044-5463
Container-title:Journal of Child and Adolescent Psychopharmacology
language:en
Short-container-title:Journal of Child and Adolescent Psychopharmacology

Author:

Ince Ezgi¹,Algedik Pinar²,Demirdogen Ezgi Sen²,Emul Murat¹,Demir Turkay²

Affiliation:

1. Department of Psychiatry, Medical School of Cerrahpasa, İstanbul University, İstanbul, Turkey.

2. Department of Child and Adolescent Psychiatry, Medical School of Cerrahpasa, İstanbul University, İstanbul, Turkey.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Psychiatry and Mental health,Pediatrics, Perinatology and Child Health

Link

http://www.liebertpub.com/doi/pdf/10.1089/cap.2014.0148

Reference13 articles.

1. Risperidone Effects in the Presence/Absence of Psychostimulant Medicine in Children with ADHD, Other Disruptive Behavior Disorders, and Subaverage IQ

2. Diagnostic and Statistical Manual of Mental Disorders

3. Methylphenidate-Induced Orofacial and Extremity Dyskinesia

4. Methylphenidate Treatment and Dyskinesia in Children with Attention-Deficit/Hyperactivity Disorder

5. MEDICATION-INDUCED HYPOMANIA IN — ASPERGER'S DISORDER

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute Hyperkinetic Movement Disorders as a Multifactorial Pharmacodynamic Drug Interaction Between Methylphenidate and Risperidone in Children and Adolescents;Journal of Clinical Psychopharmacology;2022-05

2. Safety and tolerability of antipsychotic agents in neurodevelopmental disorders: a systematic review;Expert Opinion on Drug Safety;2020-09-29

3. Movement disorders and use of risperidone and methylphenidate: a review of case reports and an analysis of the WHO database in pharmacovigilance;European Child & Adolescent Psychiatry;2020-07-03

4. Executive function in XXY : Comparison of performance‐based measures and rating scales;American Journal of Medical Genetics Part C: Seminars in Medical Genetics;2020-06

5. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies;Cochrane Database of Systematic Reviews;2018-05-10